Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on understanding the best treatment approaches of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Todd Bauer as the primary speaker and Dr. Ullas Batra as a moderator who will share the important facts associated with treatment approaches for management of ALK positive lung cancer.
Dr. Todd Bauer has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, a discussion on all possible treatment approaches and their pros, cons are discussed.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
How wildfires pose challenges to cancer care
2.
New policy review highlights the importance of health-related quality of life in advanced cancer
3.
ASCO Expert Roundtable: Breast Cancer: Expert Roundtable from the American Society of Clinical Oncology
4.
Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries
5.
The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.
1.
Evidence-Based Pathways for Survivorship Care Planning
2.
Managing Acute Respiratory Failure in Hematological Malignancies
3.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
Integrated Frameworks in Hematology in Clinical Decision-Making
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation